Rapamycin shows promise in slowing Alzheimer’s disease progression linked to seizures

FHS
May 2, 2024
4:37 pm

Protein imbalances that increase brain cell excitability may explain why individuals with Alzheimer’s disease (AD) who also experience seizures demonstrate more rapid cognitive decline than those who do not experience seizures.

AbbVie CSO Tom Hudson to retire, replaced by medical chief

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 11, 2024

Opinion | Our Patients With Disabilities Face Unique Environmental Risks

Lowe Taylor is a physiatrist. In 2018, I was a young medical resident working on a spinal cord injury unit at the Palo Alto Veterans

September 15, 2024

PsA Raises Mortality Risk, but Unevenly

Swedes with psoriatic arthritis (PsA) tended to die earlier than other people, a national case-control study indicated, but the risk varied considerably among different subgroups.

December 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.